Astrazeneca AB and another v KRKA, d.d.Novo Mesto and another

Injunction – Interlocutory. The claimants appealed against an award to the defendants of a sum in excess of £27m on an inquiry as to the damages they had suffered as a result of an interim injunction, restraining the defendants from marketing a drug pending trial. The Court of Appeal, Civil Division, in dismissing the appeal, considered the general principles to be applied in assessing the damages payable under a cross-undertaking given in respect of the grant of an interim injunction and held that, in all the circumstances, the judge had been entitled to have drawn the overall conclusions he had.

Category: